Bruker Net Invested Capital vs Good Will Analysis
BRKR Stock | USD 57.07 0.85 1.51% |
Bruker financial indicator trend analysis is way more than just evaluating Bruker prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bruker is a good investment. Please check the relationship between Bruker Net Invested Capital and its Good Will accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.
Net Invested Capital vs Good Will
Net Invested Capital vs Good Will Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bruker Net Invested Capital account and Good Will. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Bruker's Net Invested Capital and Good Will is 0.89. Overlapping area represents the amount of variation of Net Invested Capital that can explain the historical movement of Good Will in the same time period over historical financial statements of Bruker, assuming nothing else is changed. The correlation between historical values of Bruker's Net Invested Capital and Good Will is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Invested Capital of Bruker are associated (or correlated) with its Good Will. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Good Will has no effect on the direction of Net Invested Capital i.e., Bruker's Net Invested Capital and Good Will go up and down completely randomly.
Correlation Coefficient | 0.89 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Net Invested Capital
The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.Good Will
An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.Most indicators from Bruker's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bruker current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.At this time, Bruker's Selling General Administrative is relatively stable compared to the past year. As of 11/22/2024, Sales General And Administrative To Revenue is likely to grow to 0.26, while Tax Provision is likely to drop slightly above 82.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.2B | 1.3B | 1.5B | 1.6B | Total Revenue | 2.4B | 2.5B | 3.0B | 3.1B |
Bruker fundamental ratios Correlations
Click cells to compare fundamentals
Bruker Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bruker fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.8B | 3.0B | 3.7B | 3.6B | 4.2B | 4.5B | |
Total Stockholder Equity | 917.1M | 975.6M | 1.1B | 1.1B | 1.4B | 1.4B | |
Non Current Assets Total | 975.2M | 1.1B | 1.2B | 1.5B | 2.1B | 2.2B | |
Non Currrent Assets Other | 16.8M | 39.6M | 70.8M | (99.8M) | 175.7M | 184.5M | |
Other Assets | 77.3M | 180M | 160.9M | 208.9M | 240.2M | 252.2M | |
Common Stock Shares Outstanding | 156.6M | 154.6M | 152.9M | 149.4M | 147.2M | 143.8M | |
Liabilities And Stockholders Equity | 2.8B | 3.0B | 3.7B | 3.6B | 4.2B | 4.5B | |
Non Current Liabilities Total | 1.2B | 1.3B | 1.6B | 1.6B | 1.6B | 1.7B | |
Other Stockholder Equity | (333.8M) | (450.7M) | (582.5M) | (828.7M) | (954.3M) | (906.6M) | |
Total Liab | 1.9B | 2.1B | 2.6B | 2.5B | 2.8B | 3.0B | |
Short Long Term Debt Total | 860.3M | 891.5M | 1.3B | 1.2B | 1.4B | 1.4B | |
Other Current Liab | 388.8M | 210.1M | 234.4M | 596.8M | 316.2M | 237.4M | |
Total Current Liabilities | 645.6M | 793.6M | 938.5M | 913.8M | 1.2B | 1.3B | |
Property Plant And Equipment Net | 371.7M | 462.9M | 406.1M | 487M | 691.4M | 726.0M | |
Net Debt | 182M | 209.7M | 266M | 573.7M | 891.3M | 935.9M | |
Retained Earnings | 1.3B | 1.4B | 1.7B | 1.9B | 2.3B | 2.4B | |
Accounts Payable | 118.4M | 134.6M | 147.4M | 178.4M | 202.7M | 212.8M | |
Cash | 678.3M | 681.8M | 1.1B | 645.5M | 488.3M | 311.3M | |
Cash And Short Term Investments | 684.9M | 731.8M | 1.2B | 645.5M | 488.3M | 358.2M | |
Net Receivables | 362.2M | 335.3M | 416.9M | 595.3M | 621.8M | 652.9M | |
Inventory | 577.2M | 692.3M | 710.1M | 803.7M | 968.3M | 1.0B | |
Other Current Assets | 172M | 165.6M | 176.6M | 72.3M | 85.8M | 108.0M | |
Property Plant And Equipment Gross | 371.7M | 462.9M | 406.1M | 487M | 1.2B | 1.3B | |
Total Current Assets | 1.8B | 1.9B | 2.5B | 2.1B | 2.2B | 1.1B | |
Accumulated Other Comprehensive Income | (25.5M) | 3.7M | (8.2M) | 14.8M | 6M | 5.7M | |
Short Term Debt | 500K | 23.5M | 130.3M | 35.1M | 144.5M | 151.7M | |
Intangible Assets | 603.5M | 229.1M | 211.8M | 270.9M | 330.5M | 196.5M | |
Other Liab | 311M | 389.4M | 404.9M | 318.2M | 365.9M | 384.2M | |
Long Term Debt | 812.8M | 842.3M | 1.2B | 1.2B | 1.2B | 1.2B | |
Short Term Investments | 0.0 | 6.6M | 50M | 100M | 12M | 11.4M | |
Property Plant Equipment | 306.1M | 395.5M | 406.1M | 487M | 560.1M | 588.1M | |
Current Deferred Revenue | 137.9M | 189.2M | 197.5M | 225.7M | 400M | 420M | |
Treasury Stock | (543.8M) | (667M) | (820.3M) | (1.1B) | (976.5M) | (927.7M) | |
Good Will | 293M | 320.4M | 339.5M | 457.6M | 582.6M | 611.7M | |
Net Tangible Assets | 491.5M | 509.6M | 312.5M | 1.2B | 1.4B | 1.5B | |
Noncontrolling Interest In Consolidated Entity | 10.3M | 13.1M | 14.1M | 11.9M | 13.7M | 8.2M | |
Retained Earnings Total Equity | 1.3B | 1.4B | 1.7B | 1.9B | 2.2B | 2.3B | |
Long Term Debt Total | 812.8M | 842.3M | 1.2B | 1.2B | 1.4B | 1.4B |
Pair Trading with Bruker
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bruker position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will appreciate offsetting losses from the drop in the long position's value.Moving together with Bruker Stock
Moving against Bruker Stock
0.81 | EXEL | Exelixis | PairCorr |
0.74 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.56 | EWTX | Edgewise Therapeutics | PairCorr |
0.45 | KTTAW | Pasithea Therapeutics | PairCorr |
The ability to find closely correlated positions to Bruker could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bruker when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bruker - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bruker to buy it.
The correlation of Bruker is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bruker moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bruker moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bruker can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Bruker Stock Analysis
When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.